Related Experiment Video
Updated: Sep 28, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Renal function and effect of aminoglycoside therapy during the first ten days of life
Vasilios I Giapros1, Styliani K Andronikou, Vasilios I Cholevas
1Neonatology Clinic, Child Health Department, University of Ioannina Medical School, PO Box 1186, Ioannina 451 10, Greece.
Insights
Aminoglycoside antibiotics can impact kidney function in newborns. Preterm infants show more significant kidney tubular disturbances than full-term infants, depending on the specific drug used.
Area of Science:
- Neonatal Nephrology
- Pharmacology
- Pediatric Infectious Diseases
Background:
- Aminoglycosides are commonly used antibiotics in neonates to treat infections.
- Kidney function and maturation are critical in newborns, especially preterm infants.
- The impact of aminoglycosides on immature renal tubules requires further investigation.
Purpose of the Study:
- To evaluate the effect of aminoglycoside administration on kidney functional maturation in preterm and full-term infants.
- To compare the renal tubular function changes induced by different aminoglycosides.
- To assess the influence of gestational age on aminoglycoside-induced nephrotoxicity.
Main Methods:
- Groups of preterm (32.5–33.6 weeks) and full-term infants received one of three aminoglycosides for 7 days.
- Renal tubular function was assessed by measuring fractional excretion of sodium (FENa), potassium (FEK), phosphorus (FEP), magnesium (FEMg), uric acid (FEUA), and the calcium/creatinine (UCa/UCr) ratio.
- Control groups of preterm and full-term infants not receiving antibiotics were used for comparison.
Main Results:
- Aminoglycosides affected the normal decline in plasma creatinine (PCr) in both preterm and full-term infants.
- Disturbances in FENa and UCa/UCr were more pronounced in treated preterm infants compared to full-term infants, particularly with netilmicin and gentamicin.
- FEMg was significantly affected in preterm infants treated with gentamicin.
Conclusions:
- The nephrotoxic effects of aminoglycosides on renal tubular function are dependent on kidney maturity.
- The specific type of aminoglycoside administered influences the degree of renal tubular dysfunction.
- Preterm infants are more susceptible to aminoglycoside-induced renal tubular disturbances than full-term infants.
Abstract:
The effect of aminoglycoside administration on kidney functional maturation was evaluated in groups of 30 preterm and 30 fullterm infants who were treated for 7 days because of suspected infection. One of three different aminoglycosides was administered to each subgroup of ten preterm and ten fullterm infants. Changes in tubular function in groups of ten preterm and ten fullterm infants who were not given antibiotics were also compared. The mean gestational age for preterm infants from 32.5 to 33.6 weeks and for fullterm infants between 39.2 and 39.5 weeks. The renal tubular function was assessed by examining the fractional excretion of sodium (FENa), potassium (FEK), phosphorus (FEP), magnesium (FEMg) and uric acid (FEUA) as well as by the urinary excretion of calcium as the calcium/creatinine (UCa/UCr) ratio. Gentamicin affected the normal plasma creatinine (PCr) decline in both treated groups (fullterm and preterm). Disturbances in FENa and UCa/UCr were more pronounced in treated preterm than in fullterm infants especially after netilmicin and gentamicin administration. FEMg was significantly affected in preterm infants treated with gentamicin. The findings of this study indicate that the effect of aminoglycosides on tubular function is dependent upon kidney maturity and the type of the aminoglycoside used for therapy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Acute Kidney Injury V: Interprofessional Care
